Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to determine the effect of Stratacel® wound dressing on cosmetic outcomes following 1064/532nm picosecond laser (Picoway®, Syneron Candela Corp, Wayland, MA, USA) treatment of abdominal striae alba. Secondary objectives include examining the effect of Stratacel® wound dressing on post-laser healing and symptomatology.


Clinical Trial Description

Twenty adult subjects with abdominal striae alba will be enrolled. All striae will be treated using the 1064/532nm picosecond laser with designated and standardized settings (Appendix A). The abdominal striae treatment region will then be split across the body vertically with one half randomized to Stratacel® and the other to placebo, clear ultrasound gel (Aquasonic). A blinded study coordinator will apply the products to each randomized half-abdomen immediately following laser treatment.

A total of 3 treatments will be completed at 1 month intervals. Blinded-investigator and subject self-assessments will be performed at post-treatment days 2, 5, 7, and 10 after each laser session. Assessments will also be performed 1 and 3 months after the final laser treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03750422
Study type Interventional
Source Goldman, Butterwick, Fitzpatrick and Groff
Contact
Status Active, not recruiting
Phase N/A
Start date July 1, 2018
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT04165226 - LLLT and Fractional CO2 Laser in the Treatment of Stria Alba N/A
Recruiting NCT04092881 - Efficacy of Short Pulsed 1064 nm Nd-YAG Laser Versus 10600 nm Fractional CO2 Laser in Treatment of Striae Alba N/A